13D Filing: Smith Robert J and TherapeuticsMD Inc. (NYSEMKT:TXMD)

Page 6 of 11

Page 6 of 11 – SEC Filing

CUSIP No. 88338N 10 7 Page 6 of 11 Pages

Item 1.

Security and Issuer

The class of equity securities to which this Schedule 13D relates is the common stock, $0.001 par value, of TherapeuticsMD, Inc., a Nevada corporation (“Company” or “Issuer”). The address of the principal executive office of the Company is 6800 Broken Sound Parkway NW, Third Floor, Boca Raton, FL 33487.

Item 2.

Identity and Background.

(a)     Names: Robert J. Smith, Energy Capital, LLC (“Energy Capital”), Plato & Associates, LLC (“Plato”) and Jo Cee, LLC (“Jo Cee”), entities solely controlled by Mr. Smith (the “Reporting Persons”).

(b)     Residence or Business Address of Reporting Persons:

13650 Fiddlesticks Blvd., Suite 202-324, Ft. Myers, FL 33912.

(c)       Present principal occupation or employment of Reporting Persons: Business development and investments.

(d)     During the last five years, the Reporting Persons have not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e)     During the last five years, the Reporting Persons have not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding violation with respect to such laws.

(f)     Citizenship: Mr. Smith is a citizen of the United States of America.

Item 3.

Source and Amount of Funds or Other Consideration.

PF-Personal Funds

Acquisition of Shares of the Issuer by Conversion of Debt

As previously reported, Energy Capital owned a convertible promissory note in the principal amount of $105,000 (the “Note”). On October 18, 2011, the Company and Energy Capital, on behalf of itself and its assigns, entered into a Debt Conversion Agreement to convert the Note into an aggregate of 10,000,000 shares (the “Converted Shares”). Energy Capital received 7,750,000 of the Converted Shares.

As previously reported, on July 28, 2011, the Company sold a Senior Secured Promissory Note (the “Secured Note”) to Plato & Associates, LLC (“Plato”) in the amount of $500,000 and also entered into a Security Agreement under which the Company pledged all of its assets to secure the obligation. The Secured Note accrued interest at the rate of six percent (6%) per annum, was due on the one (1) year anniversary thereof, and was convertible into shares of the Company’s Common Stock at the option of the Company. On June 19, 2012, in accordance with the terms thereof, the Company and Plato agreed to convert the Secured Note plus interest into 1,387,167 shares of the Company’s Common Stock at $.038 per share.

Follow Therapeuticsmd Inc. (NYSEMKT:TXMD)

Page 6 of 11